New Key Statistics Module, Z-Score and F-Score
OTCPK:PLSH Key Ratios
| Market Cap $ M | 1.96 |
| Enterprise Value $ M | 2.19 |
| P/E(ttm) | 3.08 |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.52 |
| Price/Sales | 2.43 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | 0.03 |
| Beneish M-Score | -6.17 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 1.26 |
| EV-to-EBITDA | 0.87 |
| PEG | -- |
| Shares Outstanding M | 21.22 |
| Net Margin (%) | 91.29 |
| Operating Margin % | -160.28 |
| Pre-tax Margin (%) | 91.29 |
| Quick Ratio | 0.03 |
| Current Ratio | 15.75 |
| ROA % (ttm) | 8.74 |
| ROE % (ttm) | 10,000.00 |
| ROIC % (ttm) | -8.92 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.43 |
PLSH Number of Guru Trades
PLSH Volume of Guru Trades
Gurus Latest Trades with OTCPK:PLSH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:PLSH is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Panacea Life Sciences Holdings Inc Insider Transactions
No Available Data
News about OTCPK:PLSH
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers